FSD Pharma Inc. in INK Research

February 3, 2023

Morning Report: As the Fed makes progress on inflation, FSD advances Lucid-MS.

Canada's morning overview of insider filings with a special focus on companies that may interest active and momentum-oriented investors.

Email Alerts

Receive most valuable updates straight into your inbox

Please send investor relations inquiries to the following email:

Please send all other inquiries to the following email: